Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pensions And Benefits topic
No spam. Unsubscribe anytime.
Subcommittee backs executive spending plan for Retiree Health Care Authority after presentation on solvency
Summary
The Appropriations & Finance subcommittee accepted the executive recommendation for the Retiree Health Care Authority's budget and asked staff to review small differences with the Legislative Finance Committee recommendation after a budget briefing that highlighted improved funded status and ongoing monitoring of liabilities.
The Appropriations & Finance subcommittee accepted the executive recommendation on the Retiree Health Care Authority’s fiscal 2026 spending request and asked staff to review a small difference between the executive and Legislative Finance Committee recommendations.
Agency officials told the panel the authority remains solvent well past mid-century after a series of policy and funding steps. “We do have a current solvency beyond 2055,” Neil Kiefer, director of the Retiree Health Care Authority, told the subcommittee during the presentation. Kiefer said the authority now serves about 66,000 retirees and more than 93,000 active employees who contribute through payroll, and that the trust fund balances had grown substantially over the past decade.
The authority asked for roughly $5.2 million in additional expenditure authority tied to program growth; officials told the panel 99% of spending goes to health-care benefits administration while about 1% supports program operations. Joseph Simon, the subcommittee analyst, said the dollar difference between the LFC and executive recommendations is “a very small difference” — under $200,000 on a budget of more than $400 million — and is concentrated in transfer and program-support line items.
Kiefer walked the committee through the authority’s annual solvency review and financial metrics. He said the authority’s actuarial reporting under GASB 74 showed a total OPEB liability of roughly $3.3 billion and assets of about $1.7 billion, putting the funded ratio near 47 percent. Kiefer cautioned the panel that claims costs and federal policy changes have pushed liabilities up recently; he cited changes tied to the federal Inflation Reduction Act as among the drivers affecting prescription costs.
Members asked staff and agency officials for clarifications about last year’s reversions and trust-fund contributions. Representative Duncan asked whether the authority reverted unspent funds; Kiefer said some contractual funds reverted and, after checking with his CFO, reported the amount was about $225,000.
The authority said it continues to add to the trust fund when revenues exceed expenses and uses a 7% trend assumption in projections. Officials also said they plan to propose a Senate joint resolution to protect the trust fund and its member contributions from future transfers.
The subcommittee motion to adopt the executive recommendation included a request that staff review differences between the two budget recommendations; the committee adopted the motion with no objections recorded in the hearing transcript.
The authority stood for questions after the presentation and provided follow-up contact information for financial details staff could not answer on the spot.
